Choi_ Nikolai stock.adobe.com News Weight loss and diabetes medication GLP-1 agonists may interfere with cancer imaging, new study finds The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research presented at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM'25) has revealed. GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023
The matrix physically blocks drug penetration, and bacteria inside biofilms alter their metabolic state in ways that make standard antibiotics far less effective
doi: 10.3390/jfb11030067 Summary Keywords wound healing, pro-inflammatory, diabetes mellitus, cytokines, therapeutic approach Citation Nirenjen S, Narayanan J, Tamilanban T, Subramaniyan V, Chitra V, Fuloria NK, Wong LS, Ramachawolran G, Sekar M, Gupta G, Fuloria S, Chinni S and Selvaraj S (2023) Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes
Used for soft-tissue injuries, tendon and ligament repair, joint pain, and gastrointestinal recovery
A collective statistical analysis including the results of published studies indicates the effectiveness of steroid therapy leading to the improvement of vision in more than 80% of eyes
Pantopoulos K, Weiss G, Hentze MW
